Literature DB >> 1058243

Observations on the epidemiology of Rift Valley fever in Kenya.

F G Davies.   

Abstract

The epizootic range of Rift Valley fever in Kenya is defined from the results of virus isolations during epizootics, and form an extensive serological survey of cattle which were exposed during an epizootic. A study of the sera from a wide range of wild bovidae sampled immediately after the epizootic, showed that they did not act as reservoir or amplifying hosts for RVF. Virus isolation attempts from a variety of rodents proved negative. Rift Valley fever did not persist between epizootics by producing symptomless abortions in cattle in areas within its epizootic range. A sentinel herd sampled annually after an epizootic in 1968 revealed not one single seroconversion from 1969 to 1974. Certain forest and forest edge situations were postulated as enzootic for Rift Valley fever, and a small percentage of seroconversions were detected in cattle in these areas, born four years after the last epizootic. This has been the only evidence for the persistence of the virus in Kenya since 1968, and may be a part of the interepizootic maintenance cycle for Rift Valley fever in Kenya, which otherwise remains unknown.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1058243      PMCID: PMC2130298          DOI: 10.1017/s0022172400047252

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  20 in total

1.  Rift valley fever in South Africa. 2. The occurrence of human cases in the Orange Free State, the North-Western Cape Province, the Western and Southern Transvaal. B. Field and laboratory investigation.

Authors:  J GEAR; B DE MEILLON; V MEASROCH; D H S DAVIS; H HARWIN
Journal:  S Afr Med J       Date:  1951-12-08

2.  Fluorescent and neutralizing antibody response to infection by Rift Valley fever virus.

Authors:  A Pini; L J Lund; F G Davies
Journal:  J S Afr Vet Assoc       Date:  1973-06       Impact factor: 1.474

3.  The pathogenicity of Rift Valley fever virus for the baboon.

Authors:  F G Davies; B Clausen; L J Lund
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

4.  Arbovirus epizootics involving man, mosquitoes and vertebrates at Lunyo, Uganda 1968.

Authors:  B E Henderson; A W McCrae; B G Kirya; Y Ssenkubuge; S D Sempala
Journal:  Ann Trop Med Parasitol       Date:  1972-09

5.  The isolation of ephemeral fever virus from cattle and Culicoides midges in Kenya.

Authors:  F G Davies; A R Walker
Journal:  Vet Rec       Date:  1974-07-20       Impact factor: 2.695

6.  Rift Valley fever. 1. Vector studies in the field.

Authors:  B M McIntosh
Journal:  J S Afr Vet Med Assoc       Date:  1972-12

7.  Isolation of arboviruses in Kenya, 1966-1971.

Authors:  D Metselaar; B E Henderson; G B Kirya; P M Tukei; A de Geus
Journal:  Trans R Soc Trop Med Hyg       Date:  1974       Impact factor: 2.184

8.  The distribution in Kenya of bluetongue virus and antibody, and the Culicoides vector.

Authors:  F G Davies; A R Walker
Journal:  J Hyg (Lond)       Date:  1974-04

9.  A preliminary survey of the epidemiology of bluetongue in Kenya.

Authors:  A R Walker; F G Davies
Journal:  J Hyg (Lond)       Date:  1971-03

10.  Observations on the epidemiology of ephemeral fever in Kenya.

Authors:  F G Davies; T Shaw; P Ochieng
Journal:  J Hyg (Lond)       Date:  1975-10
View more
  44 in total

Review 1.  Emerging infectious diseases: the Bunyaviridae.

Authors:  Samantha S Soldan; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

2.  Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen.

Authors:  Bonto Faburay; William C Wilson; Arss Secka; Barbara Drolet; D Scott McVey; Juergen A Richt
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

3.  Bluetongue studies with sentinel cattle in Kenya.

Authors:  F G Davies
Journal:  J Hyg (Lond)       Date:  1978-04

Review 4.  A review of mosquitoes associated with Rift Valley fever virus in Madagascar.

Authors:  Luciano M Tantely; Sébastien Boyer; Didier Fontenille
Journal:  Am J Trop Med Hyg       Date:  2015-03-02       Impact factor: 2.345

5.  Comparison of techniques for demonstrating antibodies to Rift Valley fever virus.

Authors:  R Swanepoel; J K Struthers; M J Erasmus; S P Shepherd; G M McGillivray; B J Erasmus; B J Barnard
Journal:  J Hyg (Lond)       Date:  1986-10

6.  Patterns of Rift Valley fever activity in Zambia.

Authors:  F G Davies; E Kilelu; K J Linthicum; R G Pegram
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

7.  Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep.

Authors:  R Swanepoel; J K Struthers; M J Erasmus; S P Shepherd; G M McGillivray; A J Shepherd; D E Hummitzsch; B J Erasmus; B J Barnard
Journal:  J Hyg (Lond)       Date:  1986-10

8.  An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98.

Authors:  Christopher W Woods; Adam M Karpati; Thomas Grein; Noel McCarthy; Peter Gaturuku; Eric Muchiri; Lee Dunster; Alden Henderson; Ali S Khan; Robert Swanepoel; Isabelle Bonmarin; Louise Martin; Philip Mann; Bonnie L Smoak; Michael Ryan; Thomas G Ksiazek; Ray R Arthur; Andre Ndikuyeze; Naphtali N Agata; Clarence J Peters
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

9.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

10.  Interepidemic Rift Valley fever virus seropositivity, northeastern Kenya.

Authors:  A Desiree LaBeaud; Eric M Muchiri; Malik Ndzovu; Mariam T Mwanje; Samuel Muiruri; Clarence J Peters; Charles H King
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.